✦ LIBER ✦

NICE `yes' for ocriplasmin and enzalutamide

✍ Scribed by Pearson, Amber L.; Breetzke, Gregory D.

Book ID: 121609284
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 111 KB
Volume: 690
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-013-0845-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NICE says yes to ocriplasmin

📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

NICE recommends enzalutamide for prostat

NICE recommends enzalutamide for prostate cancer

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Final NICE yes for ranibizumab .

✍ Spyns, Peter; D’Halleweyn, Elisabeth 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

NICE guidance on enzalutamide for metast

NICE guidance on enzalutamide for metastatic hormone-relapsed prostate cancer

✍ Elsada, Ahmed; Pearce, Fiona; George, Elisabeth; Adler, Amanda 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 45 KB

NICE says yes to afatinib for NSCLC

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 200 KB

Enzymatic Vitreolysis with Ocriplasmin f

Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes

✍ Stalmans, Peter; Benz, Matthew S.; Gandorfer, Arnd; Kampik, Anselm; Girach, Aniz 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 631 KB